- Home
- CTCX vs VRAX Comparison
CTCX vs VRAX Comparison
Compare CTCX & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTCX
- VRAX
- Stock Information
- Founded
- CTCX 2007
- VRAX 2013
- Country
- CTCX United States
- VRAX United Kingdom
- Employees
- CTCX N/A
- VRAX N/A
- Industry
- CTCX Medical/Dental Instruments
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CTCX Health Care
- VRAX Health Care
- Exchange
- CTCX Nasdaq
- VRAX Nasdaq
- Market Cap
- CTCX 10.4M
- VRAX 7.3M
- IPO Year
- CTCX N/A
- VRAX 2022
- Fundamental
- Price
- CTCX $0.32
- VRAX $1.67
- Analyst Decision
- CTCX
- VRAX
- Analyst Count
- CTCX 0
- VRAX 0
- Target Price
- CTCX N/A
- VRAX N/A
- AVG Volume (30 Days)
- CTCX 1.1M
- VRAX 319.2K
- Earning Date
- CTCX 03-31-2025
- VRAX 02-05-2025
- Dividend Yield
- CTCX N/A
- VRAX N/A
- EPS Growth
- CTCX N/A
- VRAX N/A
- EPS
- CTCX N/A
- VRAX N/A
- Revenue
- CTCX $32,839.00
- VRAX $84,872.00
- Revenue This Year
- CTCX N/A
- VRAX $5,169.18
- Revenue Next Year
- CTCX N/A
- VRAX $66.97
- P/E Ratio
- CTCX N/A
- VRAX N/A
- Revenue Growth
- CTCX N/A
- VRAX 7.03
- 52 Week Low
- CTCX $0.20
- VRAX $0.60
- 52 Week High
- CTCX $4.00
- VRAX $9.00
- Technical
- Relative Strength Index (RSI)
- CTCX 40.82
- VRAX 38.42
- Support Level
- CTCX $0.37
- VRAX $1.55
- Resistance Level
- CTCX $0.49
- VRAX $2.20
- Average True Range (ATR)
- CTCX 0.08
- VRAX 0.25
- MACD
- CTCX -0.02
- VRAX -0.07
- Stochastic Oscillator
- CTCX 0.84
- VRAX 12.37
About CTCX Carmell Corporation
Carmell Corp is a bio-aesthetics company that utilizes the Carmell Secretome to support skin and hair health. Its cosmetic skincare product portfolio includes Carmell G.L.E.E and various others in pipeline such as Youth restoring formula, Ultra-brightening formula, Ultra-hydrating formula, and Rapid Recovery formula among others. The company has one operating segment, principally the business of developing and commercializing bio-aesthetics and its bone and tissue healing products.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.